Nomination Committee for Acarix Annual General Meeting 2025
A Nomination Committee consisting of shareholder representatives and the Chairman of the Board of Directors has been established for Ac...
Acarix Publishes Third Quarter 2024 Report
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the third quarter of 202...
Invitation to presentation of Acarix´s third quarter 2024 report
Correction: Correction refers to the publication of the Q3 presentation occurring after the release of the financial report.Acarix invi...
Integrated Delivery Network (IDN) Places Order of the Acarix CADScor System
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce placement of four (4) CADScor systems and ...
Invitation to presentation of Acarix´s third quarter 2024 report
Acarix invites investors, analysts, and media to a webcast presentation of the third quarter report for 2024 on November 7, 15:00 CET. ...
Acarix Expands U.S. Reimbursement Coverage for CADScor System for use in Emergency and Outpatient Settings
Malmö, Sweden — Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announced today that the U.S. Centers ...
Acarix Secures Expansion Order from Existing CADScor System Customer
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that a current customer has placed an orde...
Multi-Location Customer Places Order of the Acarix CADScor System with Goal to Scale Usage
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce the sale of 9 CADScor Systems and 500 sing...
Acarix resolves on a directed issue to the guarantors of the warrant series 3
Acarix AB ("Acarix" or the "Company") today announces that the Board of Directors has resolved on a directed issue to the guarantors of...
Acarix announces outcome of warrant exercise of series 3
Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise of warrants of series 3 issued in connection with the...
Board member purchases shares in Acarix
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces that Dr. Tony Daz, Board member of Acarix, purchased 2,000,6...
Acarix informs of exercise price for the warrants of series TO 3
Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the exercise price ...